286 related articles for article (PubMed ID: 32691018)
1. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism.
Fox DB; Garcia NMG; McKinney BJ; Lupo R; Noteware LC; Newcomb R; Liu J; Locasale JW; Hirschey MD; Alvarez JV
Nat Metab; 2020 Apr; 2(4):318-334. PubMed ID: 32691018
[TBL] [Abstract][Full Text] [Related]
2. De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling.
Del Vecchio CA; Feng Y; Sokol ES; Tillman EJ; Sanduja S; Reinhardt F; Gupta PB
PLoS Biol; 2014 Sep; 12(9):e1001945. PubMed ID: 25203443
[TBL] [Abstract][Full Text] [Related]
3. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species.
Kitano Y; Baba Y; Nakagawa S; Miyake K; Iwatsuki M; Ishimoto T; Yamashita YI; Yoshida N; Watanabe M; Nakao M; Baba H
J Pathol; 2018 Mar; 244(3):346-357. PubMed ID: 29243822
[TBL] [Abstract][Full Text] [Related]
5. Cellular dormancy in minimal residual disease following targeted therapy.
Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
[TBL] [Abstract][Full Text] [Related]
7. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance.
Singh A; Bodas M; Wakabayashi N; Bunz F; Biswal S
Antioxid Redox Signal; 2010 Dec; 13(11):1627-37. PubMed ID: 20446773
[TBL] [Abstract][Full Text] [Related]
8. Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway.
Deng R; Zhu Y; Liu K; Zhang Q; Hu S; Wang M; Zhang Y
Bioorg Chem; 2024 Apr; 145():107212. PubMed ID: 38377819
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
10. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.
Luo M; Shang L; Brooks MD; Jiagge E; Zhu Y; Buschhaus JM; Conley S; Fath MA; Davis A; Gheordunescu E; Wang Y; Harouaka R; Lozier A; Triner D; McDermott S; Merajver SD; Luker GD; Spitz DR; Wicha MS
Cell Metab; 2018 Jul; 28(1):69-86.e6. PubMed ID: 29972798
[TBL] [Abstract][Full Text] [Related]
11. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence.
Vera-Ramirez L; Vodnala SK; Nini R; Hunter KW; Green JE
Nat Commun; 2018 May; 9(1):1944. PubMed ID: 29789598
[TBL] [Abstract][Full Text] [Related]
12. Lipid Profile and Aquaporin Expression under Oxidative Stress in Breast Cancer Cells of Different Malignancies.
Rodrigues C; Milkovic L; Bujak IT; Tomljanovic M; Soveral G; Cipak Gasparovic A
Oxid Med Cell Longev; 2019; 2019():2061830. PubMed ID: 31379986
[TBL] [Abstract][Full Text] [Related]
13. "NRF2 addiction" in lung cancer cells and its impact on cancer therapy.
Hammad A; Namani A; Elshaer M; Wang XJ; Tang X
Cancer Lett; 2019 Dec; 467():40-49. PubMed ID: 31574294
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
15. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells.
Khalil HS; Langdon SP; Goltsov A; Soininen T; Harrison DJ; Bown J; Deeni YY
Oncotarget; 2016 Nov; 7(46):75874-75901. PubMed ID: 27713148
[TBL] [Abstract][Full Text] [Related]
17. NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.
Khalil HS; Langdon SP; Kankia IH; Bown J; Deeni YY
Oxid Med Cell Longev; 2016; 2016():4148791. PubMed ID: 26770651
[TBL] [Abstract][Full Text] [Related]
18. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
19. Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training.
Gounder SS; Kannan S; Devadoss D; Miller CJ; Whitehead KJ; Odelberg SJ; Firpo MA; Paine R; Hoidal JR; Abel ED; Rajasekaran NS
PLoS One; 2012; 7(9):e45697. PubMed ID: 23029187
[TBL] [Abstract][Full Text] [Related]
20. Progressive Rotavirus Infection Downregulates Redox-Sensitive Transcription Factor Nrf2 and Nrf2-Driven Transcription Units.
Patra U; Mukhopadhyay U; Mukherjee A; Sarkar R; Chawla-Sarkar M
Oxid Med Cell Longev; 2020; 2020():7289120. PubMed ID: 32322337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
